- Zinc Finger Nuclease (ZFN)
- Clustered regularly interspaced short palindromic repeats (CRISPR)
- Transcription activator-like effector nuclease (TALEN)
- Others
Gene Editing Market size was valued at USD 4.98 billion in 2022 and is expected to reach USD 16.36 billion by 2029, at a CAGR of 18.5% during the forecast period 2023-2029. Gene editing or genome editing is the type of genetic editing where DNA is inserted, replaced, or deleted in the genome of an organism in order to treat a specific disease by using molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in the genome. The induced double-stranded breaks are repaired through nonhomologous end-joining or homologous recombination resulting in targeted mutations (edits). Biotechnology and pharmaceutical sectors dominate the gene-editing market due to their applications in drug discovery and therapeutics. Rise in the usage of CRISPR and ZFN, companies are investing in innovative research for the development of novel gene-editing techniques. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers, and acquisitions, strategic or manufacturing activities that are driving the growth of the gene-editing market. For instance, in 2014, Thermo Fisher acquired Life technologies, to create unbeatable leadership in life sciences insrumentation, research, specialty diagnostics, and applied markets. In 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Rise in the prevalence rate of cancer & other genetic disorders, increasing preference in the personalized medicine, companies investments towards R&D, and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and gene editing technologies, applications in various drug discovery processes are some of the factors propelling the growth of the gene-editing market. However, the global gene editing market is hindered by stringent government regulations to approve gene mutation projects, ethical issues, unavailability of gene editing-based therapeutics in the market, and lack of awareness among people regarding the safety of genetic interventions.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Global Gene Editing Market Introduction |
2.1. Global Gene Editing Market – Taxonomy |
2.2. Global Gene Editing Market –Definitions |
2.2.1. Product Type |
2.2.2. Technology |
2.2.3. Application |
2.2.4. Region |
3. Global Gene Editing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Current Trends |
3.5. Global Gene Editing Market Dynamic Factors - Impact Analysis |
3.6. Mergers, Acquisitions, and Collaborations |
4. Global Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Gene Editing Market, By Product Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1. Reagents & Consumables |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Software & Systems |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Services |
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Gene Editing Market, By Technology, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1. CRISPR |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. TALEN |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. ZFN |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Antisense |
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Gene Editing Market, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.1. Cell Line Engineering |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Genetic Engineering |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Applications |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Drug Discovery & Development |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Gene Editing Market, By End User, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1. Pharmaceutical and Biotechnology Companies |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Academic and Research Institutes |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Contract Research Organizations |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Gene Editing Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific |
9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. MEA |
9.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, and Country, 2022 - 2028 |
10. North America Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Reagents & Consumables |
10.1.2. Software & Systems |
10.1.3. Services |
10.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. CRISPR |
10.2.2. TALEN |
10.2.3. ZFN |
10.2.4. Antisense |
10.2.5. Others |
10.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.3.1. Cell Line Engineering |
10.3.2. Genetic Engineering |
10.3.3. Diagnostic Applications |
10.3.4. Drug Discovery & Development |
10.3.5. Others |
10.4. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Pharmaceutical and Biotechnology Companies |
10.4.2. Academic and Research Institutes |
10.4.3. Contract Research Organizations |
10.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.5.1. United States |
10.5.2. Canada |
10.6. North America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027 |
10.7. North America Gene Editing Market Dynamics – Trends |
11. Europe Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
11.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents & Consumables |
11.1.2. Software & Systems |
11.1.3. Services |
11.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. CRISPR |
11.2.2. TALEN |
11.2.3. ZFN |
11.2.4. Antisense |
11.2.5. Others |
11.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.3.1. Cell Line Engineering |
11.3.2. Genetic Engineering |
11.3.3. Diagnostic Applications |
11.3.4. Drug Discovery & Development |
11.3.5. Others |
11.4. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Pharmaceutical and Biotechnology Companies |
11.4.2. Academic and Research Institutes |
11.4.3. Contract Research Organizations |
11.5. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.5.1. UK |
11.5.2. Germany |
11.5.3. France |
11.5.4. Italy |
11.5.5. Spain |
11.5.6. Rest of Europe |
11.6. Europe Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027 |
11.7. Europe Gene Editing Market Dynamics – Trends |
12. Asia Pacific Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
12.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents & Consumables |
12.1.2. Software & Systems |
12.1.3. Services |
12.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. CRISPR |
12.2.2. TALEN |
12.2.3. ZFN |
12.2.4. Antisense |
12.2.5. Others |
12.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.3.1. Cell Line Engineering |
12.3.2. Genetic Engineering |
12.3.3. Diagnostic Applications |
12.3.4. Drug Discovery & Development |
12.3.5. Others |
12.4. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.4.1. Pharmaceutical and Biotechnology Companies |
12.4.2. Academic and Research Institutes |
12.4.3. Contract Research Organizations |
12.5. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. ANZ |
12.5.4. Japan |
12.5.5. Rest of APAC |
12.6. Asia Pacific Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027 |
12.7. Asia Pacific Gene Editing Market Dynamics – Trends |
13. MEA Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
13.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents & Consumables |
13.1.2. Software & Systems |
13.1.3. Services |
13.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. CRISPR |
13.2.2. TALEN |
13.2.3. ZFN |
13.2.4. Antisense |
13.2.5. Others |
13.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.3.1. Cell Line Engineering |
13.3.2. Genetic Engineering |
13.3.3. Diagnostic Applications |
13.3.4. Drug Discovery & Development |
13.3.5. Others |
13.4. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Pharmaceutical and Biotechnology Companies |
13.4.2. Academic and Research Institutes |
13.4.3. Contract Research Organizations |
13.5. Country Level Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.5.1. GCC Countries |
13.5.2. South Africa |
13.5.3. Rest of MEA |
13.6. MEA Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027 |
13.7. MEA Gene Editing Market Dynamics – Trends |
14. Latin America Gene Editing Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
14.1. Product Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Reagents & Consumables |
14.1.2. Software & Systems |
14.1.3. Services |
14.2. Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. CRISPR |
14.2.2. TALEN |
14.2.3. ZFN |
14.2.4. Antisense |
14.2.5. Others |
14.3. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.3.1. Cell Line Engineering |
14.3.2. Genetic Engineering |
14.3.3. Diagnostic Applications |
14.3.4. Drug Discovery & Development |
14.3.5. Others |
14.4. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.4.1. Pharmaceutical and Biotechnology Companies |
14.4.2. Academic and Research Institutes |
14.4.3. Contract Research Organizations |
14.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.5.1. Brazil |
14.5.2. Mexico |
14.5.3. Argentina |
14.5.4. Rest of LA |
14.6. Latin America Gene Editing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and End User, 2016-2027 |
14.7. Latin America Gene Editing Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Merck KGaA |
15.2.2. Sangamo |
15.2.3. Editas Medicine |
15.2.4. Precision Biosciences |
15.2.5. CRISPR Therapeutics |
15.2.6. Intellia Therapeutics, Inc. |
15.2.7. Caribou Biosciences, Inc. |
15.2.8. Cellectis S.A. |
15.2.9. AstraZeneca |
15.2.10. Integrated DNA Technologies, Inc. |
15.2.11. Egenesis Inc. |
15.2.12. GenScript |
15.2.13. OriGene Technologies, Inc. |
15.2.14. Lonza |
15.2.15. Thermo Fisher Scientific, Inc. |
16. Research Methodology |
17. Key Assumptions and Acronyms |